G01N 2333/982
Asparaginase
G01N2333/982 (Asparaginase) appears on 2 US grants and 5 published applications in this corpus.
Search patents in G01N- Granted patents
- 2
- Published applications
- 5
- Assignees
- 6
- Inventors
- 7
- Latest grant
- 28 Feb 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Analytical method and therapeutical agent for use in combination with l-asparaginase in tumour therapy19 Jun 2025US 2025/0195628 A1Medizinische Hochschule Hannover
- Asparaginase therapeutic methods30 Dec 2021US 2021/0401953 A1Dana-Farber Cancer Institute, Inc.
- Asrgl1 in endometrial cancer25 Feb 2016US 2016/0054324 A1Atlas Antibodies AB
- Test for Predicting Neutralization of Asparaginase Activity12 Mar 2015US 2015/0071894 A1Erytech Pharma
- Test for Predicting Neutralization of Asparaginase Activity17 May 2012US 2012/0121570 A1Erytech Pharma
Most cited
By later US patents